ReviewMedical oncology (Northwood, London, England)2025
Targeting racial disparities in breast cancer: mechanistic insights and therapeutic potential of African medicinal plants.
Review in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review examines the multifaceted disparities in breast cancer outcomes between African American and European American women, with a focus on molecular drivers, epigenetic determinants, and the therapeutic potential of African medicinal plants. It addresses three key questions: (1) What biological mechanisms underlie racial disparities in breast cancer aggressiveness and survival? (2) How do gene-environment interactions contribute to these disparities? (3) Can African medicinal plants offer targeted solutions for high-risk populations?. A non-systematic literature search was conducted across PubMed, Web of Science, and Scopus using keywords such as "breast cancer disparities," "African American women," "tumor microenvironment," "DNA methylation," and "African medicinal plants." English-language studies were prioritized, encompassing molecular oncology, epidemiology, and ethnopharmacology. Data were synthesized into thematic areas like biological mechanisms and plant-derived therapies. AA women exhibit distinct tumor biology, including hypermethylation of tumor suppressors (RARB, CDH13), gene mutations (TP53), and pro-inflammatory microenvironments with elevated cytokines (IL-6, CCL5). Social determinants like structural racism and healthcare access barriers exacerbate outcomes. African medicinal plants like Vernonia amygdalina (IC
Indexed as
Identifiers
40730932What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.